Two ClōSYS Alcohol-Free Oral Health Rinses are the first mouth rinses to be awarded the ADA Seal of Acceptance for the management of oral malodor. Continue reading→

Banner Alzheimer’s Institute Receives Added NIH Support – Five-year funding expected to total $14.8 million to support groundbreaking Alzheimer’s Prevention InitiativeContinue reading→

Allscripts shareholders elected biotech industry executive Mara G. Aspinall  to  the company’s Board of Directors.  Continue reading→

Continue reading→

Sergio Gazic, former Bioscience Portfolio Manager at the Arizona Commerce Authority, began his  new role as Chief Executive Officer of BioAccel on Monday, May 22, 2017. Continue reading→

EpiFinder, Inc., announced its proprietary clinical decision analytics software to improve epilepsy syndrome diagnosis and seizure event management at the point-of-care. The early-stage Arizona company provides intelligent analytics and support to doctors, neurologists and healthcare professionals (Nurse Practitioners, Physician Assistants, and more) to enhance the lives of patients with epilepsy.Continue reading→

Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and healthcare-associated infections.Continue reading→

 On May 12, 2017, Governor Doug Ducey signed Arizona’s $9.8 billion 2018-2019 Budget which provides bonding authority for $1 billion for investments in University Research Infrastructure.    This investment continues a collaboration between the State of Arizona, Industry Leaders, Philanthropists, and Arizona’s Universities that is driving Arizona towards its goal of becoming a top-tier bioscience state.Continue reading→